This is the new MLex platform. Existing customers should continue to use the existing MLex platform until migrated.
For any queries, please contact Customer Services or your Account Manager. Dismiss

Antitrust Europe | 1 Nov 2024

( November 1, 2024, 07:02 GMT | Press Round-Up Europe) -- Contents: -Teva fined in EU for MS drug tactics -Nvidia, Run:ai deal to undergo EU review -Vestager defends EU court record -Czech authority rejects complaints in nuclear plant deal -Porsche cleared in Germany for Varta stake -Temu comes under EU scrutiny over digital sellingThe European Commission has imposed a fine of 462.2 million euros on Teva for abusing its market power through patent strategies related to its Copaxone drug....

Prepare for tomorrow’s regulatory change, today

MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.


Know what others in the room don’t, with features including:

  • Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
  • Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
  • Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
  • Curated case files bringing together news, analysis and source documents in a single timeline

Experience MLex today with a 14-day free trial.

Start Free Trial

Already a subscriber? Click here to login